Accelerating research and development of new vaccines against tuberculosis: a global roadmap
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Accelerating research and development of new vaccines against tuberculosis: a global roadmap
Authors
Keywords
-
Journal
LANCET INFECTIOUS DISEASES
Volume 22, Issue 4, Pages e108-e120
Publisher
Elsevier BV
Online
2022-03-01
DOI
10.1016/s1473-3099(21)00810-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment
- (2021) Olivier J Wouters et al. LANCET
- Vaccine hesitancy in the era of COVID-19
- (2021) Gianmarco Troiano et al. PUBLIC HEALTH
- Affordability of Adult Tuberculosis Vaccination in India and China: A Dynamic Transmission Model-Based Analysis
- (2021) Chathika Krishan Weerasuriya et al. Vaccines
- SARS-CoV-2 vaccines: a triumph of science and collaboration
- (2021) Jonathan L. Golob et al. JCI Insight
- Controlled Human Infection Models – Is it Really Feasible to Give People Tuberculosis?
- (2020) Helen McShane AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Exhaled Mycobacterium tuberculosis output and detection of subclinical disease by face-mask sampling: prospective observational studies
- (2020) Caroline M Williams et al. LANCET INFECTIOUS DISEASES
- Prevention of tuberculosis in macaques after intravenous BCG immunization
- (2020) Patricia A. Darrah et al. NATURE
- Concise whole blood transcriptional signatures for incipient tuberculosis: a systematic review and patient-level pooled meta-analysis
- (2020) Rishi K Gupta et al. Lancet Respiratory Medicine
- Cell-Mediated Immune Responses to in vivo-Expressed and Stage-Specific Mycobacterium tuberculosis Antigens in Latent and Active Tuberculosis Across Different Age Groups
- (2020) Mariateresa Coppola et al. Frontiers in Immunology
- The case for assessing the full value of new tuberculosis vaccines
- (2020) Nebiat Gebreselassie et al. EUROPEAN RESPIRATORY JOURNAL
- New live attenuated tuberculosis vaccine MTBVAC induces trained immunity and confers protection against experimental lethal pneumonia
- (2020) Raquel Tarancón et al. PLoS Pathogens
- BCG Vaccination in Humans Elicits Trained Immunity via the Hematopoietic Progenitor Compartment
- (2020) Branko Cirovic et al. Cell Host & Microbe
- Subclinical tuberculosis disease - a review and analysis of prevalence surveys to inform definitions, burden, associations and screening methodology
- (2020) Beatrice Frascella et al. CLINICAL INFECTIOUS DISEASES
- Potential impact of tuberculosis vaccines in China, South Africa, and India
- (2020) Rebecca C. Harris et al. Science Translational Medicine
- DAR-901 vaccine for the prevention of infection with Mycobacterium tuberculosis among BCG-immunized adolescents in Tanzania: A randomized controlled, double-blind phase 2b trial
- (2020) Patricia Munseri et al. VACCINE
- Prevention of tuberculosis infection and disease by local BCG in repeatedly exposed rhesus macaques
- (2019) Karin Dijkman et al. NATURE MEDICINE
- Age-targeted tuberculosis vaccination in China and implications for vaccine development: a modelling study
- (2019) Rebecca C Harris et al. Lancet Global Health
- IFN-γ-independent immune markers of Mycobacterium tuberculosis exposure
- (2019) Lenette L. Lu et al. NATURE MEDICINE
- Patent pooling to increase access to essential medicines
- (2019) Esteban Burrone et al. BULLETIN OF THE WORLD HEALTH ORGANIZATION
- Unmasking the hidden tuberculosis mortality burden in a large postmortem study in Maputo Central Hospital, Mozambique
- (2019) Alberto L. Garcia-Basteiro et al. EUROPEAN RESPIRATORY JOURNAL
- Insights and challenges in tuberculosis vaccine development
- (2019) Helen McShane Lancet Respiratory Medicine
- Preferred product characteristics for therapeutic vaccines to improve tuberculosis treatment outcomes: Key considerations from World Health Organization consultations
- (2019) Johan Vekemans et al. VACCINE
- A Human Lung Challenge Model to Evaluate the Safety and Immunogenicity of PPD and Live BCG
- (2019) Malika Davids et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis
- (2019) Dereck R. Tait et al. NEW ENGLAND JOURNAL OF MEDICINE
- Incipient and Subclinical Tuberculosis: a Clinical Review of Early Stages and Progression of Infection
- (2018) Paul K. Drain et al. CLINICAL MICROBIOLOGY REVIEWS
- Prevention of tuberculosis in rhesus macaques by a cytomegalovirus-based vaccine
- (2018) Scott G Hansen et al. NATURE MEDICINE
- Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination
- (2018) Elisa Nemes et al. NEW ENGLAND JOURNAL OF MEDICINE
- WHO preferred product characteristics for new vaccines against tuberculosis
- (2018) Lewis K Schrager et al. LANCET INFECTIOUS DISEASES
- Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis
- (2018) Olivier Van Der Meeren et al. NEW ENGLAND JOURNAL OF MEDICINE
- The role of National Immunisation Technical Advisory Groups (NITAGs) in strengthening national vaccine decision-making: A comparative case study of Armenia, Ghana, Indonesia, Nigeria, Senegal and Uganda
- (2018) Natasha Howard et al. VACCINE
- Current approaches toward identifying a correlate of immune protection from tuberculosis
- (2018) Iman Satti et al. Expert Review of Vaccines
- Metabolite changes in blood predict the onset of tuberculosis
- (2018) January Weiner et al. Nature Communications
- Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis disease
- (2017) Thomas J. Scriba et al. PLoS Pathogens
- The Recombinant Bacille Calmette–Guérin Vaccine VPM1002: Ready for Clinical Efficacy Testing
- (2017) Natalie E. Nieuwenhuizen et al. Frontiers in Immunology
- TBVAC2020: Advancing Tuberculosis Vaccines from Discovery to Clinical Development
- (2017) Stefan H. E. Kaufmann et al. Frontiers in Immunology
- A Functional Role for Antibodies in Tuberculosis
- (2016) Lenette L. Lu et al. CELL
- Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure
- (2016) Stephanus T Malherbe et al. NATURE MEDICINE
- Characterization of progressive HIV-associated tuberculosis using 2-deoxy-2-[18F]fluoro-D-glucose positron emission and computed tomography
- (2016) Hanif Esmail et al. NATURE MEDICINE
- Trained immunity: A program of innate immune memory in health and disease
- (2016) M. G. Netea et al. SCIENCE
- Alternative BCG delivery strategies improve protection against Mycobacterium tuberculosis in non-human primates: Protection associated with mycobacterial antigen-specific CD4 effector memory T-cell populations
- (2016) S. Sharpe et al. TUBERCULOSIS
- Systematic review of mathematical models exploring the epidemiological impact of future TB vaccines
- (2016) Rebecca C. Harris et al. Human Vaccines & Immunotherapeutics
- Co-evolution ofMycobacterium tuberculosisandHomo sapiens
- (2015) Daniela Brites et al. IMMUNOLOGICAL REVIEWS
- Immunology studies in non-human primate models of tuberculosis
- (2015) JoAnne L. Flynn et al. IMMUNOLOGICAL REVIEWS
- High expression of CD26 accurately identifies human bacteria-reactive MR1-restricted MAIT cells
- (2015) Prabhat K. Sharma et al. IMMUNOLOGY
- WHO's new End TB Strategy
- (2015) Mukund Uplekar et al. LANCET
- Distinct, Specific IL-17- and IL-22-Producing CD4+ T Cell Subsets Contribute to the Human Anti-Mycobacterial Immune Response
- (2014) T. J. Scriba et al. JOURNAL OF IMMUNOLOGY
- Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries
- (2014) G. M. Knight et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Protection by BCG Vaccine Against Tuberculosis: A Systematic Review of Randomized Controlled Trials
- (2013) Punam Mangtani et al. CLINICAL INFECTIOUS DISEASES
- Early clearance ofMycobacterium tuberculosis: a new frontier in prevention
- (2013) Ayesha J. Verrall et al. IMMUNOLOGY
- Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial
- (2013) Michele D Tameris et al. LANCET
- Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes
- (2012) J. Kleinnijenhuis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MVA.85A Boosting of BCG and an Attenuated, phoP Deficient M. tuberculosis Vaccine Both Show Protective Efficacy Against Tuberculosis in Rhesus Macaques
- (2009) Frank A. W. Verreck et al. PLoS One
- Role of M. tuberculosis RD-1 region encoded secretory proteins in protective response and virulence
- (2008) Niladri Ganguly et al. TUBERCULOSIS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started